This is a working overview of semax, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2026-07-08 and is reviewed periodically as new material appears.
The compound is registered in Russia as a pharmaceutical product, most commonly formulated as a nasal solution, and has been used in that setting since the 1990s. Outside that jurisdiction it is generally handled as a research chemical rather than an approved medicine. Regulatory status therefore differs sharply between countries, and material sold internationally may not correspond to the Russian pharmaceutical formulation. Documentation with commercial samples is typically limited to a certificate of analysis covering purity and identity, not clinical status or local legal classification.
Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. It corresponds to the ACTH(4-7) fragment extended at the C-terminus by a Pro-Gly-Pro tripeptide, an addition intended to slow enzymatic breakdown. The molecular formula is C37H51N9O10S and the molecular mass is approximately 814 daltons. In the literature it is often described as an ACTH(4-10) analog, although that label reflects a naming convention as much as a precise structural relationship. The compound was developed in Russia and remains most closely associated with that research tradition.
The proposed mechanism centres on neurotrophic signalling rather than direct receptor activation. Semax is reported to increase expression of brain-derived neurotrophic factor and nerve growth factor in several brain regions, and to shift the balance between excitatory and inhibitory neurotransmitter systems. Interaction with melanocortin receptors has been suggested because of the parent ACTH fragment. Many of these findings come from rodent studies, and the extent to which they translate to human physiology remains an open question.
Scientific literature on semax is unevenly distributed. A substantial share of published work originates from a small number of laboratories in Russia, while independent replication elsewhere is limited. Human data consist mostly of small trials with short follow-up, and several reported outcomes rely on subjective rating scales. Questions about how much intact peptide reaches the central nervous system after nasal administration, and how long it persists there, are still unresolved. The compound is best described as an active research subject rather than a settled pharmacological agent.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C37H51N9O10S | Contains one methionine sulfur atom |
| Molecular mass | Approximately 814 Da | Consistent with a seven-residue peptide |
| Appearance | White to off-white powder | Typical lyophilized form |
| Solubility | Freely soluble in water | Also soluble in dimethyl sulfoxide |
| Typical storage | -20 °C, desiccated | Limits methionine oxidation |
研究兴趣主要集中在神经营养因子相关的路径上，包括脑源性神经营养因子与神经生长因子的表达变化。部分实验报告称在特定条件下观察到这些因子的水平上升，但具体信号通路和剂量依赖关系仍未完全厘清。多数公开数据来自细胞模型和动物实验，人体对照研究数量有限。因此，该化合物的作用机制在文献中属于活跃讨论，而非已经确立的定论。
Semax 是一种人工合成的七肽，氨基酸序列为 Met-Glu-His-Phe-Pro-Gly-Pro，单字母缩写记作 MEHFPGP。它被归类为促肾上腺皮质激素片段 ACTH(4-10) 的结构类似物，但并不天然存在于生物体内。母体片段 ACTH(4-10) 的序列为 Met-Glu-His-Phe-Arg-Trp-Gly，Semax 替换了中间两个残基，并在羧基端延长了 Pro-Gly-Pro 三肽。这种延长被普遍认为能提升分子对肽酶的耐受性。
Clinical evidence consists largely of small trials with modest sample sizes, often without independent replication. Reported endpoints include cognitive scores, recovery after stroke, and visual function, but study designs vary widely and few trials meet contemporary reporting standards. Systematic reviewers have noted a high risk of bias in several of these reports. No large multicenter trial conducted outside Russia has been published. The compound is therefore best described as investigational in most jurisdictions, with its clinical role still unresolved.
Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. Its chain combines the first seven residues of corticotropin with a C-terminal proline-glycine-proline extension, a modification intended to slow enzymatic breakdown. The free peptide has a molecular mass near 813.9 daltons. It belongs to the class of ACTH-derived fragments studied for central nervous system activity rather than for adrenal steroid stimulation. This structural relationship to a natural hormone fragment is the usual starting point for describing the compound in the literature.
Regulatory status varies sharply by country. Semax is registered for medical use in Russia, where it appears in formularies as a nasal solution, and it also holds registration in a small number of neighbouring states. It has no approval from the United States Food and Drug Administration or the European Medicines Agency, and it is not a scheduled controlled substance in most jurisdictions. Elsewhere it circulates mainly as laboratory material, so purity documentation comes from suppliers rather than from a national pharmacopoeia.
Semax is a synthetic peptide created in the Soviet Union during the early 1980s by researchers working in Moscow. It was built from the short adrenocorticotropic hormone fragment known as ACTH(4-10), and the chain was then extended with three additional amino acids. The resulting molecule was named semax and entered clinical use in Russia in 1994. It is generally described as a nootropic and neuroprotective agent rather than as a hormone analogue.
The parent fragment ACTH(4-10) carries the sequence Met-Glu-His-Phe-Arg-Trp-Gly. Semax replaces the arginine and tryptophan positions with a proline-glycine-proline tail, giving Met-Glu-His-Phe-Pro-Gly-Pro. That change removes residues associated with adrenal stimulation, so the peptide does not drive cortisol release the way full ACTH does. This distinction shapes how the compound is grouped in the literature, where it sits with neuropeptides and peptide neuromodulators rather than with corticosteroids.
Clinical reports describe use in ischaemic stroke, transient ischaemic attack, optic nerve conditions, and cognitive complaints, but most of these studies are small and were conducted in a single region. Systematic reviews have generally described the evidence base as limited in size and variable in methodological quality. Randomised controlled data suitable for international regulatory assessment are scarce. As a result, major treatment guidelines outside Russia do not include the peptide, and interest in it remains largely research-driven rather than routine clinical.
Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. It is described in the literature as an analogue of the ACTH(4–10) fragment, a short N-terminal portion of adrenocorticotropic hormone that retains some neurotropic activity without the full hormonal effects of the parent peptide. The molecule carries a methionine residue at the N-terminus and two proline residues near the C-terminus, features that shape both its interactions with receptor systems and its chemical stability. The free peptide corresponds to the formula C37H51N9O10S and a molecular mass near 813.9 Da.
The compound was developed in the 1980s at the Institute of Molecular Genetics in Moscow, where it emerged from research on short ACTH fragments and their effects on the central nervous system. Russian pharmaceutical listings describe it as a nootropic and neuroprotective agent, most often formulated as nasal drops. It is not a marketed medicine in the United States or the European Union, and no pharmacopoeial monograph covers it. Consequently, most published clinical experience with the substance originates from a small number of research centres, mainly in Russia and neighbouring countries.
Charles Herbert Best (February 27, 1899 – March 31, 1978), was an American-Canadian medical scientist and one of the co-discoverers of insulin with Frederick Banting. He served as the chair of the Banting and Best Department of Medical Research at the University of Toronto and was further involved in research concerning choline and heparin.
Max Vasmer's etymological dictionary traces the name to the Tatar Turkic word kazak, kozak, in which cosac meant 'free man' but also 'conqueror'. The ethnonym Kazakh is from the same Turkic root. In written sources, the name is first attested in the Codex Cumanicus from the 13th century. Larysa Pritsak (2024) grouped the earliest references of the word Cossack(s) into three groups:
The medical anthropologist Charles Leslie writes that Chinese, Greco-Arabic, and Indian traditional medicines were all grounded in systems of correspondence that aligned the organization of society, the universe, and the human body and other forms of life into an "all-embracing order of things". Each of these traditional systems was organized with such qualities as heat and cold, wet and dry, light and darkness, qualities that also align the seasons, compass directions, and the human cycle of birth, growth, and death. They provided, Leslie continued, a "comprehensive way of conceiving patterns that ran through all of nature," and they "served as a classificatory and mnemonic device to observe health problems and to reflect upon, store, and recover empirical knowledge," but they were also "subject to stultifying theoretical elaboration, self-deception, and dogmatism." The doctrines of Chinese medicine are rooted in books such as the Yellow Emperor's Inner Canon and the Treatise on Cold Damage, as well as in cosmological notions such as yin–yang and the five phases. The Compendium of Materia Medica dates back to around 1,100 BCE when only a few dozen drugs were described. By the end of the 16th century, the number of drugs documented had reached close to 1,900. And by the end of the last century, published records of CMM had reached 12,800 drugs." Starting in the 1950s, these precepts were standardized in the People's Republic of China, including attempts to integrate them with modern notions of anatomy and pathology.
Veneer is obtained either by "peeling" the trunk of a tree or by slicing large rectangular blocks of wood known as flitches. The appearance of the grain and figure in wood comes from slicing through the growth rings of a tree and depends upon the angle at which the wood is sliced. There are three main types of veneer-making equipment used commercially:
Sources: en.wikipedia.org
Under Bello's direction, SoBe launched a line of "3C" Elixirs (containing calcium, carnitine and chromium) in varieties such as Orange-Carrot, Orange-Tomato (including lycopene), Energy (with guarana, yohimbe and arginine), Power (taurine, creatine and proline), Zen Blend (triple ginseng tea with schizandra), Wisdom (with ginkgo biloba, St. John's wort and gotu kola) and Eros (with dong quai, damiana, foti and zink). Other fun SoBe products included Lizzard Blizzard, Tsunami, Fierce, Courage and Long John Lizard’s Grape Grog. He created the "dueling lizards" design and took a lead role in the company's guerrilla marketing effort, proclaiming himself as the "Lizard King" in radio advertisements. He gave the brand an "attitude" by enlisting athletes who were somewhat out of the mainstream—such as golfer John Daly and downhill skier Bode Miller—as official spokespersons for the brand. The SoBe marketing team also wooed independent beverage distributors, offering them very high margins and a small chunk of equity in the company. From its creation in 1995, SoBe's sales rose rapidly and climbed to $275 million by 2000. The following year, the brand rode the "good-for-you" trend among American consumers to break the quarter billion dollar barrier in 2000. SoBe was sold to PepsiCo for a reported $370 million cash on October 30, 2000. Bello remained with Pepsi overseeing SoBe until early 2004. By the end of 1999 the company had sold 14.8 million cases of drinks and taken in $166.4 million.
=== Election misinformation === Ayyadurai has continued to spread misinformation since about the 2020 presidential election. At Mike Lindell's Cyber Symposium in August 2021, he claimed there were "serious issues" in the election process involving voting machines able to "multiply a vote by a factor" and that states were illegally not "saving ballot images". In fact, not all states are legally required to store ballot images. In August 2021, he was hired by the Arizona Senate—as part of the controversial 2021 Maricopa County presidential ballot audit—to "review signatures on the envelopes of 1.9 million early ballots sent to [Maricopa] county". In late September, he remotely attended the Arizona state senate presentation of the review's findings where he questioned the validity of some signatures on mail ballot envelopes, and criticized and gave a presentation filled with misrepresentations about the county's signature verification process.
The metals nickel, chromium, and copper coated with silver have been used to make the normally thin-wired e-cigarette heating elements. The atomizers and heating coils possibly contain aluminum. They likely account for most of the aluminum in the e-cigarette vapor. The chromium used to make the atomizers and heating coils is probably the origin of the chromium. Copper is commonly used to make atomizers. Atomizers and heating coils commonly contain iron. Cadmium, lead, nickel, and silver originated from the heating element. Silicate particles may originate from the fiberglass wicks. Silicate nanoparticles have been found in vapors generated from the fiberglass wicks. Tin may originate from the e-cigarette solder joints. Nickel potentially found in the e-cigarette vapor may originate from the atomizer and heating coils. The nanoparticles can be produced by the heating element or by pyrolysis of chemicals directly touching the wire surface. Chromium, iron, tin, and nickel nanoparticles potentially found in the e-cigarette vapor can originate from the e-cigarette heating coils. Kanthal and nichrome are frequently used heating coils which may account for chromium and nickel in the e-cigarette vapor. Metals can originate from the "cartomizer" from the later-generation devices where an atomizer and cartridge are constructed into one unit. Metal and glass particles can be created and vaporized because of the heating of the liquid with glass fiber.
double-stranded Composed of two antiparallel, complementary nucleic acid molecules or strands (either DNA–DNA, RNA–RNA, or a DNA–RNA hybrid) which are held together by hydrogen bonds between the complementary nucleobases of each strand, known as base pairing. Compare single-stranded.
At the very end of the T-loop, the single-stranded telomere DNA is held onto a region of double-stranded DNA by the telomere strand disrupting the double-helical DNA and base pairing to one of the two strands. This triple-stranded structure is called a displacement loop or D-loop.
Sources: en.wikipedia.org
==== Economic reform ==== Libya's economy witnessed increasing privatization; although rejecting the socialist policies of nationalized industry advocated in The Green Book, government figures asserted that they were forging "people's socialism" rather than capitalism. Gaddafi welcomed these reforms, calling for wide-scale privatization in a March 2003 speech; he promised that Libya would join the World Trade Organization. These reforms encouraged private investment in Libya's economy. By 2004, there was US$40 billion of direct foreign investment in Libya, a six-fold rise over 2003. Sectors of Libya's population reacted against these reforms with public demonstrations, and in March 2006, revolutionary hard-liners took control of the GPC cabinet; although scaling back the pace of the changes, they did not halt them. In 2010, plans were announced that would have seen half the Libyan economy privatized over the next decade, these plans appear to have been soon abandoned however, as the companies that the government stated they were going to float on the stock market, among them the National Commercial Bank and the Libyan Iron and Steel Company were never floated and remained 100% state-owned. Many socialist policies remained however, with subsidiaries of logistics company HB Group being nationalized in 2007. Agriculture remained largely untouched by the reforms, with farms remaining cooperatives, the Agricultural Bank of Libya remaining wholly state-owned and state interventionist policies and price controls remaining.
Expression. The 5-HT3C, 5-HT3D and 5-HT3E genes tend to show peripherally restricted pattern of expression, with high levels in the gut. In human duodenum and stomach, for example, 5-HT3C and 5-HT3E mRNA might be greater than for 5-HT3A and 5-HT3B. Polymorphism. In patients treated with chemotherapeutic drugs, certain polymorphism of the HTR3B gene could predict successful antiemetic treatment. This could indicate that the 5-HTR3B receptor subunit could be used as biomarker of antiemetic drug efficacy.
== History == Photoionization has a long history of use in mass spectrometry experiments, though mostly for research purposes and not for sensitive analytical applications. Pulsed lasers have been used for non-resonant multiphoton ionization (MPI), resonance-enhanced MPI (REMPI) using tunable wavelengths, and single-photon ionization using sum frequency generation in non-linear media (usually gas cells). Non-laser sources of photoionization include discharge lamps and synchrotron radiation. The former sources were not adaptable to high sensitivity analytical applications because of low spectral brightness in the former case and large "facility-size" in the latter case. Meanwhile, photoionization has been used for GC detection and as a source for ion mobility spectrometry for many years suggesting the potential for use in mass spectrometry. The first development of APPI for LC/MS was reported by Robb, Covey, and Bruins and by Syage, Evans, and Hanold in 2000. APPI sources were commercialized shortly thereafter by Syagen Technology and made available for most commercial MS systems and by Sciex for their line of MS instruments. Concurrent to the development of APPI was a similar use of a VUV source for low pressure photoionization (LPPI) by Syage and coworkers that accepted atmospheric pressure gas phase samples but stepped down the pressure for ionization to about 1 torr (~100 Pa) before further pressure reduction for introduction into a MS analyzer. This photoionization method is well suited as an interface between gas chromatography (GC) and MS.
The third expansion for Half-Life was Decay. The game was again developed by Gearbox and published by Sierra. However, unlike previous games, Decay was released exclusively with the PlayStation 2 version of Half-Life. Decay is unique within the Half-Life series as the only cooperative game—two players must work together to progress through the game. Decay focuses on two of Freeman's colleagues, Gina Cross and Colette Green, as the two work with other scientists to counter the effects of the dimensional rift and ultimately attempt to close it. Released on November 14, 2001, Decay received a weak but overall positive reception from critics, many reviewers stating that it was fun to play through with a friend, but that the game's more puzzle-oriented gameplay detracted from the overall experience. An unofficial Windows port was released in September 2008.
==== Carbon bound hydrogen exchange ==== For some time, researchers believed that large hydrocarbon molecules were impervious to hydrogen exchange, but recent work has identified many reactions that allow isotope reordering. The isotopic exchange becomes relevant at geologic time scales and has impacted work of biologists studying lipid biomarkers, and geologists studying ancient oil. Reactions responsible for exchange include
Sources: en.wikipedia.org
It is registered as a pharmaceutical product in Russia, where it is typically supplied as a nasal solution. In most other countries it is not an approved drug and is traded as a research chemical instead. Approval status depends entirely on the jurisdiction involved.
Most published work uses intranasal administration, matching the route of the registered Russian formulation. Some animal experiments use intravenous or intraperitoneal injection. The route matters because the intact peptide is cleared rapidly from blood, so exposure differs between methods.
A purity value describes the share of the powder accounted for by the target peptide, usually by high-performance liquid chromatography. It does not confirm that the sequence is correct, which requires mass spectrometry or amino acid analysis. Purity and identity are separate checks.
Semax is based on the ACTH(4-10) fragment, a seven-amino-acid segment of adrenocorticotropic hormone. The synthetic peptide retains the core sequence while removing regions associated with endocrine activity. This modification is intended to isolate effects on the nervous system.